<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Octreotide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Octreotide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Octreotide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Octreotide</b>, sold under the brand name <b>Sandostatin</b> among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of <a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">growth hormone</a>, <a href="Glucagon.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucagon" title="Glucagon">glucagon</a>, and <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a> than the natural hormone. It was first synthesized in 1979, by the chemist Wilfried Bauer. It was approved for use in the United States in 1988.<span class="mw-ref" id="cite_ref-Bynfezia_Pen_label_1-0"><a href="#cite_note-Bynfezia_Pen_label-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Sandostatin_label_2-0"><a href="#cite_note-Sandostatin_label-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Octreotide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Octreotide.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Octreotide.svg.png" data-file-width="2652" data-file-height="2622" data-file-type="drawing" height="218" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Octreotide3d.png" tppabs="https://ptable.com/wiki/compounds/I/m/Octreotide3d.png" data-file-width="450" data-file-height="500" data-file-type="bitmap" height="244" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Sandostatin, Bynfezia Pen, Mycapssa, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/octreotide-acetate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/octreotide-acetate.html'" tppabs="https://www.drugs.com/monograph/octreotide-acetate.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a693049.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a693049.html'" tppabs="https://medlineplus.gov/druginfo/meds/a693049.html" class="external text external">a693049</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Octreotide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Octreotide'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Octreotide" class="external text external">Octreotide</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>C<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>B (No risk in non-human studies)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Subcutaneous, intramuscular, intravenous, by mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>H01CB02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=H01CB02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=H01CB02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=H01CB02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>60% (IM), 100% (SC)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>40–65%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Hepatic</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>1.7–1.9 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine (32%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(4<i>R</i>,7<i>S</i>,10<i>S</i>,13<i>R</i>,16<i>S</i>,19<i>R</i>)-10-(4-aminobutyl)-19-<br>[[(2<i>R</i>)-2-amino-3-phenyl-propanoyl]amino]-16-<br>benzyl-<i>N</i>-[(2<i>R</i>,3<i>R</i>)-1,3-dihydroxybutan-2-yl]-7-<br>(1-hydroxyethyl)-13-(1<i>H</i>-indol-3-ylmethyl)-6,9,12,<br>15,18-pentaoxo-1,2-dithia-5,8,11,14,17-<br>pentazacycloicosane-4-carboxamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=83150-76-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=83150-76-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=83150-76-9" class="external text external">83150-76-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup> <br><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=79517-01-4&title=  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=79517-01-4&title='" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=79517-01-4&title=" class="external text external">79517-01-4</a>  (acetate)<br><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=135467-16-2&title=  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=135467-16-2&title='" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=135467-16-2&title=" class="external text external">135467-16-2</a>  (<a href="Pamoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Pamoate" title="Pamoate" class="mw-redirect">pamoate</a>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/448601  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/448601'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/448601" class="external text external">448601</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2055  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2055'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2055" class="external text external">2055</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00104'" tppabs="https://www.drugbank.ca/drugs/DB00104" class="external text external">DB00104</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.395352.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.395352.html'" tppabs="http://www.chemspider.com/Chemical-Structure.395352.html" class="external text external">395352</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=RWM8CCW8GP  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=RWM8CCW8GP'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=RWM8CCW8GP" class="external text external">RWM8CCW8GP</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00442  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00442'" tppabs="https://www.kegg.jp/entry/D00442" class="external text external">D00442</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1680'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1680" class="external text external">ChEMBL1680</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID0048682  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID0048682'" tppabs="https://comptox.epa.gov/dashboard/DTXSID0048682" class="external text external">DTXSID0048682</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>49</sub><span>H</span><sub>66</sub><span>N</span><sub>10</sub><span>O</span><sub>10</sub><span>S</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">1<span style="margin-left:.25em;">019</span>.25</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=C%5BC%40H%5D%28%5BC%40H%5D1C%28%3DO%29N%5BC%40%40H%5D%28CSSC%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40H%5D%28C%28%3DO%29N1%29CCCCN%29Cc2c%5BnH%5Dc3c2cccc3%29Cc4ccccc4%29NC%28%3DO%29%5BC%40%40H%5D%28Cc5ccccc5%29N%29C%28%3DO%29N%5BC%40H%5D%28CO%29%5BC%40%40H%5D%28C%29O%29O  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=C%5BC%40H%5D%28%5BC%40H%5D1C%28%3DO%29N%5BC%40%40H%5D%28CSSC%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40H%5D%28C%28%3DO%29N1%29CCCCN%29Cc2c%5BnH%5Dc3c2cccc3%29Cc4ccccc4%29NC%28%3DO%29%5BC%40%40H%5D%28Cc5ccccc5%29N%29C%28%3DO%29N%5BC%40H%5D%28CO%29%5BC%40%40H%5D%28C%29O%29O'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=C%5BC%40H%5D%28%5BC%40H%5D1C%28%3DO%29N%5BC%40%40H%5D%28CSSC%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40H%5D%28C%28%3DO%29N1%29CCCCN%29Cc2c%5BnH%5Dc3c2cccc3%29Cc4ccccc4%29NC%28%3DO%29%5BC%40%40H%5D%28Cc5ccccc5%29N%29C%28%3DO%29N%5BC%40H%5D%28CO%29%5BC%40%40H%5D%28C%29O%29O" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)Cc2c[nH]c3c2cccc3)Cc4ccccc4)NC(=O)[C@@H](Cc5ccccc5)N)C(=O)N[C@H](CO)[C@@H](C)O)O</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C49H66N10O10S2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:DEQANNDTNATYII-OULOTJBUSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458287873&page2=Octreotide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458287873&page2=Octreotide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458287873&page2=Octreotide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Tumors">Tumors</h3></summary>
    
<p>Octreotide is used for the treatment of <a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">growth hormone</a> producing tumors (acromegaly and gigantism), when surgery is contraindicated, pituitary tumors that secrete <a href="Thyroid-stimulating_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Thyroid-stimulating_hormone" title="Thyroid-stimulating hormone">thyroid-stimulating hormone</a> (thyrotropinoma), diarrhea and <a href="Flushing_(physiology).htm" tppabs="https://ptable.com/wiki/compounds/A/Flushing_(physiology)" title="Flushing (physiology)">flushing</a> episodes associated with carcinoid syndrome, and diarrhea in people with vasoactive intestinal peptide-secreting tumors (VIPomas). Octreotide is also used in mild cases of glucagonoma when surgery is not an option.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Bleeding_esophageal_varices">Bleeding esophageal varices</h3></summary>
    
<p>Octreotide is often given as an infusion for management of acute hemorrhage from esophageal varices in liver cirrhosis on the basis that it reduces portal venous pressure, though current evidence suggests that this effect is transient and does not improve survival.<span class="mw-ref" id="cite_ref-pmid18677774_5-0"><a href="#cite_note-pmid18677774-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Radiolabeling">Radiolabeling</h3></summary>
    

<p>Octreotide is used in nuclear medicine imaging by labeling with indium-111 (Octreoscan) to noninvasively image neuroendocrine and other tumours expressing somatostatin receptors.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span>  More recently, it has been radiolabeled with carbon-11<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> as well as gallium-68, enabling imaging with positron emission tomography (PET), which provides higher resolution and sensitivity.</p>

<p>Octreotide can also be labeled with a variety of radionuclides, such as yttrium-90 or lutetium-177, to enable peptide receptor radionuclide therapy (PRRT) for the treatment of unresectable neuroendocrine tumours.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Acromegaly">Acromegaly</h3></summary>
    
<p>Octreotide can also be used in the treatment of acromegaly, a disorder of excessive growth hormone (GH). Octreotide, being a somatostatin analog, inhibits the release of GH from the pituitary gland through a process normally involved in negative feedback.</p>

<p>In June 2020, Mycapssa (octreotide) was approved for medical use in the United States with an indication for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Chiasma_Mycapssa_PR_9-0"><a href="#cite_note-Chiasma_Mycapssa_PR-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Mycapssa is the first and only oral somatostatin analog (SSA) approved by the FDA.<span class="mw-ref" id="cite_ref-Chiasma_Mycapssa_PR_9-1"><a href="#cite_note-Chiasma_Mycapssa_PR-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Gastrointestinal_fistulae">Gastrointestinal fistulae</h3></summary>
    
<p>Octreotide helps in management of the fistula by reducing gastrointestinal secretions and inhibiting gastrointestinal motility, thus controlling and reducing its output. The value in healing intestinal fistulas is yet to be proven and routine use is limited because of the side effects.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Hypoglycemia">Hypoglycemia</h3></summary>
    
<p>Octreotide is also used in the treatment of refractory hypoglycemia in neonates and sulphonylurea-induced hypoglycemia in adults.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Octreotide has not been adequately studied for the treatment of children as well as pregnant and lactating women. The drug is given to these groups only if a risk-benefit analysis is positive.<span class="mw-ref" id="cite_ref-AustriaCodex_10-0"><a href="#cite_note-AustriaCodex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Arzneistoff-Profile_11-0"><a href="#cite_note-Arzneistoff-Profile-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>The most common adverse effects are headache, hypothyroidism, cardiac conduction changes, gastrointestinal reactions (including cramps, nausea/vomiting and diarrhoea or constipation), gallstones, reduction of <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a> release, hyperglycemia<span class="mw-ref" id="cite_ref-pmid20132129_12-0"><a href="#cite_note-pmid20132129-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> or sometimes hypoglycemia, and (usually transient) injection site reactions. Slow heart rate, skin reactions such as pruritus, <a href="Bilirubin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyperbilirubinemia" title="Hyperbilirubinemia" class="mw-redirect">hyperbilirubinemia</a>, hypothyroidism, dizziness and dyspnoea are also fairly common (more than 1%). Rare side effects include acute anaphylactic reactions, pancreatitis and hepatitis.<span class="mw-ref" id="cite_ref-AustriaCodex_10-1"><a href="#cite_note-AustriaCodex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Arzneistoff-Profile_11-1"><a href="#cite_note-Arzneistoff-Profile-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Some studies reported alopecia in those who were treated by octreotide.<span class="mw-ref" id="cite_ref-pmid9391775_13-0"><a href="#cite_note-pmid9391775-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Rats which were treated by octreotide experienced erectile dysfunction in a 1998 study.<span class="mw-ref" id="cite_ref-pmid9467491_14-0"><a href="#cite_note-pmid9467491-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>A prolonged QT interval has been observed, but it is uncertain whether this is a reaction to the drug or the result of an existing illness.<span class="mw-ref" id="cite_ref-AustriaCodex_10-2"><a href="#cite_note-AustriaCodex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<table class="infobox" style="width:22em"><tbody><tr><th colspan="2" style="text-align:center;background-color: #ddd">Identifiers</th></tr><tr><th scope="row" style="background-color: #e7dcc3">Symbol</th><td style="background-color: #eee">N/A</td></tr><tr><th scope="row" style="background-color: #e7dcc3">OPM superfamily</th><td style="background-color: #eee"><a href="javascript:if(confirm('https://opm.phar.umich.edu/protein_superfamilies/158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://opm.phar.umich.edu/protein_superfamilies/158'" tppabs="https://opm.phar.umich.edu/protein_superfamilies/158" class="external text external">158</a></td></tr><tr><th scope="row" style="background-color: #e7dcc3">OPM protein</th><td style="background-color: #eee"><a href="javascript:if(confirm('https://opm.phar.umich.edu/proteins?search=1soc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://opm.phar.umich.edu/proteins?search=1soc'" tppabs="https://opm.phar.umich.edu/proteins?search=1soc" class="external text external">1soc</a></td></tr></tbody></table>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>Octreotide is useful in overdose management of sulfonylurea type hypoglycemic medications, when recurrent or refractory to parenteral dextrose.  Mechanism of action is the suppression of insulin secretion.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Octreotide can reduce the intestinal reabsorption of <a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciclosporin" title="Ciclosporin">ciclosporin</a>, possibly making it necessary to increase the dose.<span class="mw-ref" id="cite_ref-Arzneimittel-Interaktionen_15-0"><a href="#cite_note-Arzneimittel-Interaktionen-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> People with diabetes mellitus might need less <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a> or oral antidiabetics when treated with octreotide, as it inhibits glucagon secretion more strongly and for a longer time span than insulin secretion.<span class="mw-ref" id="cite_ref-AustriaCodex_10-3"><a href="#cite_note-AustriaCodex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> The bioavailability of <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a> is increased;<span class="mw-ref" id="cite_ref-Arzneistoff-Profile_11-2"><a href="#cite_note-Arzneistoff-Profile-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span>  besides being an antiparkinsonian, bromocriptine is also used for the treatment of acromegaly.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<p>Since octreotide resembles somatostatin in physiological activities, it can:</p>
<ul><li>inhibit secretion of many hormones, such as gastrin, cholecystokinin, <a href="Glucagon.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucagon" title="Glucagon">glucagon</a>, <a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">growth hormone</a>, <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a>, <a href="Secretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Secretin" title="Secretin">secretin</a>, pancreatic polypeptide, <a href="Thyroid-stimulating_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Thyroid-stimulating_hormone" title="Thyroid-stimulating hormone">TSH</a>, and vasoactive intestinal peptide,</li>
<li>reduce secretion of fluids by the intestine and pancreas,</li>
<li>reduce gastrointestinal motility and inhibit contraction of the gallbladder,</li>
<li>inhibit the action of certain hormones from the anterior pituitary,</li>
<li>cause vasoconstriction in the blood vessels, and</li>
<li>reduce portal vessel pressures in bleeding varices.</li></ul>

<p>It has also been shown to produce analgesic effects, most probably acting as a partial agonist at the mu opioid receptor.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Octreotide is absorbed quickly and completely after subcutaneous application. Maximal plasma concentration is reached after 30 minutes. The elimination half-life is 100 minutes (1.7 hours) on average when applied subcutaneously; after intravenous injection, the substance is eliminated in two phases with half-lives of 10 and 90 minutes, respectively.<span class="mw-ref" id="cite_ref-AustriaCodex_10-4"><a href="#cite_note-AustriaCodex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Arzneistoff-Profile_11-3"><a href="#cite_note-Arzneistoff-Profile-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Octreotide has also been used off-label for the treatment of severe, refractory diarrhea from other causes. It is used in toxicology for the treatment of prolonged recurrent hypoglycemia after sulfonylurea and possibly meglitinide overdose.  It has also been used with varying degrees of success in infants with nesidioblastosis to help decrease insulin hypersecretion. Several clinical trials have demonstrated the effect of octreotide as acute treatment (abortive agent) in cluster headache, where it has been shown that administration of subcutaneous octreotide is effective when compared with placebo.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Octreotide has also been investigated in people with pain from chronic pancreatitis.<span class="mw-ref" id="cite_ref-pmid10207228_19-0"><a href="#cite_note-pmid10207228-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>It has been used in the treatment of malignant bowel obstruction.<span class="mw-ref" id="cite_ref-pmid18490369_20-0"><a href="#cite_note-pmid18490369-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>Octreotide may be used in conjunction with <a href="Midodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Midodrine" title="Midodrine">midodrine</a> to partially reverse peripheral vasodilation in the hepatorenal syndrome.  By increasing systemic vascular resistance, these drugs reduce shunting and improve renal perfusion, prolonging survival until definitive treatment with liver transplant.<span class="mw-ref" id="cite_ref-pmid19238094_21-0"><a href="#cite_note-pmid19238094-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Similarly, octreotide can be used to treat refractory chronic hypotension.<span class="mw-ref" id="cite_ref-patient.info_22-0"><a href="#cite_note-patient.info-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>While successful treatment has been demonstrated in case reports,<span class="mw-ref" id="cite_ref-pmid16392238_23-0"><a href="#cite_note-pmid16392238-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-pmid16487393_24-0"><a href="#cite_note-pmid16487393-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> larger studies have failed to demonstrate efficacy in treating chylothorax.<span class="mw-ref" id="cite_ref-pmid16242470_25-0"><a href="#cite_note-pmid16242470-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>A small study has shown that octreotide may be effective in the treatment of idiopathic intracranial hypertension.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-pmid17700925_27-0"><a href="#cite_note-pmid17700925-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Obesity">Obesity</h3></summary>
    
<p>Octreotide has been used experimentally to treat obesity, particularly obesity caused by lesions in the hunger and satiety centers of the hypothalamus, a region of the brain central to the regulation of food intake and energy expenditure.<span class="mw-ref" id="cite_ref-Lustig2003_28-0"><a href="#cite_note-Lustig2003-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> The circuit begins with an area of the hypothalamus, the arcuate nucleus, that has outputs to the lateral hypothalamus (LH) and ventromedial hypothalamus (VMH), the brain's feeding and satiety centers, respectively.<span class="mw-ref" id="cite_ref-flier_29-0"><a href="#cite_note-flier-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> The VMH is sometimes injured by ongoing treatment for acute lymphoblastic leukemia (ALL) or surgery or radiation to treat posterior cranial fossa tumors.<span class="mw-ref" id="cite_ref-Lustig2003_28-1"><a href="#cite_note-Lustig2003-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> With the VMH disabled and no longer responding to peripheral energy balance signals, "Efferent sympathetic activity drops, resulting in malaise and reduced energy expenditure, and vagal activity increases, resulting in increased <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a> secretion and adipogenesis."<span class="mw-ref" id="cite_ref-Lustig2011_31-0"><a href="#cite_note-Lustig2011-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> "VMH dysfunction promotes excessive caloric intake and decreased caloric expenditure, leading to continuous and unrelenting weight gain. Attempts at caloric restriction or pharmacotherapy with adrenergic or serotonergic agents have previously met with little or only brief success in treating this syndrome."<span class="mw-ref" id="cite_ref-Lustig2003_28-2"><a href="#cite_note-Lustig2003-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> In this context, octreotide suppresses the excessive release of insulin and may increase its action, thereby inhibiting excessive adipose storage. In a small clinical trial in eighteen pediatric subjects with intractable weight gain following therapy for ALL or brain tumors and other evidence of hypothalamic dysfunction, octreotide reduced body mass index (BMI) and insulin response during glucose tolerance test, while increasing parent-reported physical activity and quality of life (QoL) relative to placebo.<span class="mw-ref" id="cite_ref-Lustig2003_28-3"><a href="#cite_note-Lustig2003-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> In a separate placebo-controlled trial of obese adults without known hypothalamic lesions, obese subjects who received long-acting octreotide lost weight and reduced their BMI compared to subjects receiving placebo; post hoc analysis suggested greater effects in patients receiving the higher dose of the drug, and among "Caucasian subjects having insulin secretion greater than the median of the cohort." "There were no statistically significant changes in QoL scores, body fat, leptin concentration, Beck Depression Inventory, or macronutrient intake", although subjects taking octreotide had higher blood glucose after a glucose tolerance test than those receiving placebo.<span class="mw-ref" id="cite_ref-Lustig2006_32-0"><a href="#cite_note-Lustig2006-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Octreotide acetate was approved for use in the United States in 1988.<span class="mw-ref" id="cite_ref-Sandostatin_label_2-1"><a href="#cite_note-Sandostatin_label-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Bynfezia_Pen_label_1-1"><a href="#cite_note-Bynfezia_Pen_label-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>In January 2020, approval of octreotide acetate in the United States was granted to Sun Pharmaceutical under the brand name Bynfezia Pen for the treatment of:<span class="mw-ref" id="cite_ref-Bynfezia_Pen_label_1-2"><a href="#cite_note-Bynfezia_Pen_label-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Bynfezia_Pen_letter_33-0"><a href="#cite_note-Bynfezia_Pen_letter-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>
<ul><li>the reduction of <a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">growth hormone</a> and insulin-like growth factor 1 (somatomedin C) in adults with acromegaly who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine mesylate</a> at maximally tolerated doses</li>
<li>severe diarrhea/flushing episodes associated with metastatic carcinoid tumors in adults</li>
<li>profuse watery diarrhea associated with vasoactive intestinal peptide tumors (VIPomas) in adults</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Octreotate, a closely related peptide</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Bynfezia_Pen_label-1"> <span id="mw-reference-text-cite_note-Bynfezia_Pen_label-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213224s000lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213224s000lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213224s000lbl.pdf" class="external text external">"Bynfezia Pen (octreotide acetate) injection, for subcutaneous use"</a> <span class="cs1-format">(PDF)</span>. Sun Pharmaceutical Industries. 28 January 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">16 February</span> 2020</span>.</cite></span></li><li id="cite_note-Sandostatin_label-2"> <span id="mw-reference-text-cite_note-Sandostatin_label-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9" class="external text external">"Sandostatin Lar Depot- octreotide acetate kit"</a>. <i>DailyMed</i>. 11 April 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">16 February</span> 2020</span>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text">Octreotide <span><a href="javascript:if(confirm('https://www.drugs.com/monograph/octreotide-acetate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/octreotide-acetate.html'" tppabs="https://www.drugs.com/monograph/octreotide-acetate.html" class="external text external">Monograph</a></span></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFMoattariChoVinik1990" class="citation journal cs1">Moattari AR, Cho K, Vinik AI (1990). "Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses". <i>Surgery</i>. <b>108</b> (3): 581–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2168587  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2168587'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2168587" class="external text external">2168587</a>.</cite></span></li><li id="cite_note-pmid18677774-5"> <span id="mw-reference-text-cite_note-pmid18677774-5" class="mw-reference-text"><cite id="CITEREFGøtzscheHróbjartsson2008" class="citation journal cs1">Gøtzsche PC, Hróbjartsson A (July 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043291  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043291'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043291" class="external text external">"Somatostatin analogues for acute bleeding oesophageal varices"</a>. <i>The Cochrane Database of Systematic Reviews</i> (3): CD000193. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD000193.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD000193.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD000193.pub3" class="external text external">10.1002/14651858.CD000193.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043291  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043291'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043291" class="external text external">7043291</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18677774  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18677774'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18677774" class="external text external">18677774</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><a href="javascript:if(confirm('http://www.medscape.com/viewarticle/406655_3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/406655_3'" tppabs="http://www.medscape.com/viewarticle/406655_3" class="external text external">Medscape: Octreoscan review</a></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFChinVesnaverBernard-GauthierSaucke-Lacelle2013" class="citation journal cs1">Chin J, Vesnaver M, Bernard-Gauthier V, Saucke-Lacelle E, Wängler B, Wängler C, Schirrmacher R (November 2013). "Direct one-step labeling of cysteine residues on peptides with [(11)C]methyl triflate for the synthesis of PET radiopharmaceuticals". <i>Amino Acids</i>. <b>45</b> (5): 1097–108. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00726-013-1562-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00726-013-1562-5'" tppabs="https://doi.org/10.1007%2Fs00726-013-1562-5" class="external text external">10.1007/s00726-013-1562-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23921782  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23921782'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23921782" class="external text external">23921782</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://chiasma.com/octreotide-capsules/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chiasma.com/octreotide-capsules/'" tppabs="https://chiasma.com/octreotide-capsules/" class="external text external">"Octreotide Capsules - Our Research"</a>. <i>Chiasma</i>. 24 January 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">30 June</span> 2020</span>.</cite></span></li><li id="cite_note-Chiasma_Mycapssa_PR-9"> <span id="mw-reference-text-cite_note-Chiasma_Mycapssa_PR-9" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://ir.chiasma.com/news-releases/news-release-details/chiasma-announces-fda-approval-mycapssar-octreotide-capsules  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ir.chiasma.com/news-releases/news-release-details/chiasma-announces-fda-approval-mycapssar-octreotide-capsules'" tppabs="https://ir.chiasma.com/news-releases/news-release-details/chiasma-announces-fda-approval-mycapssar-octreotide-capsules" class="external text external">"Chiasma Announces FDA Approval of Mycapssa (Octreotide) Capsules, the First and Only Oral Somatostatin Analog"</a>. <i>Chiasma, Inc.</i> (Press release). 26 June 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">30 June</span> 2020</span>.</cite></span></li><li id="cite_note-AustriaCodex-10"> <span id="mw-reference-text-cite_note-AustriaCodex-10" class="mw-reference-text"><cite id="CITEREFHaberfeld,_H2009" class="citation book cs1">Haberfeld, H, ed. (2009). <i>Austria-Codex</i> (in German) (2009/2010 ed.). Vienna: Österreichischer Apothekerverlag. ISBN<span>&nbsp;</span><bdi>978-3-85200-196-8</bdi>.</cite></span></li><li id="cite_note-Arzneistoff-Profile-11"> <span id="mw-reference-text-cite_note-Arzneistoff-Profile-11" class="mw-reference-text"><cite id="CITEREFDinnendahl,_VFricke,_U2010" class="citation book cs1">Dinnendahl, V; Fricke, U, eds. (2010). <i>Arzneistoff-Profile</i> (in German). <b>8</b> (23 ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag. ISBN<span>&nbsp;</span><bdi>978-3-7741-9846-3</bdi>.</cite></span></li><li id="cite_note-pmid20132129-12"> <span id="mw-reference-text-cite_note-pmid20132129-12" class="mw-reference-text"><cite id="CITEREFHovindSimonsenBülow2010" class="citation journal cs1">Hovind P, Simonsen L, Bülow J (March 2010). "Decreased leg glucose uptake during exercise contributes to the hyperglycaemic effect of octreotide". <i>Clinical Physiology and Functional Imaging</i>. <b>30</b> (2): 141–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1475-097X.2009.00917.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1475-097X.2009.00917.x'" tppabs="https://doi.org/10.1111%2Fj.1475-097X.2009.00917.x" class="external text external">10.1111/j.1475-097X.2009.00917.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20132129  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20132129'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20132129" class="external text external">20132129</a>.</cite></span></li><li id="cite_note-pmid9391775-13"> <span id="mw-reference-text-cite_note-pmid9391775-13" class="mw-reference-text"><cite id="CITEREFvan_der_Lelyde_HerderLamberts1997" class="citation journal cs1">van der Lely AJ, de Herder WW, Lamberts SW (November 1997). "A risk-benefit assessment of octreotide in the treatment of acromegaly". <i>Drug Safety</i>. <b>17</b> (5): 317–24. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002018-199717050-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002018-199717050-00004'" tppabs="https://doi.org/10.2165%2F00002018-199717050-00004" class="external text external">10.2165/00002018-199717050-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9391775  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9391775'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9391775" class="external text external">9391775</a>.</cite></span></li><li id="cite_note-pmid9467491-14"> <span id="mw-reference-text-cite_note-pmid9467491-14" class="mw-reference-text"><cite id="CITEREFKapiciogluMollamehmetogluKutluCan1998" class="citation journal cs1">Kapicioglu S, Mollamehmetoglu M, Kutlu N, Can G, Ozgur GK (January 1998). "Inhibition of penile erection in rats by a long-acting somatostatin analogue, octreotide (SMS 201-995)". <i>British Journal of Urology</i>. <b>81</b> (1): 142–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1464-410x.1998.00520.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1464-410x.1998.00520.x'" tppabs="https://doi.org/10.1046%2Fj.1464-410x.1998.00520.x" class="external text external">10.1046/j.1464-410x.1998.00520.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9467491  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9467491'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9467491" class="external text external">9467491</a>.</cite></span></li><li id="cite_note-Arzneimittel-Interaktionen-15"> <span id="mw-reference-text-cite_note-Arzneimittel-Interaktionen-15" class="mw-reference-text"><cite id="CITEREFKlopp,_T2010" class="citation book cs1">Klopp, T, ed. (2010). <i>Arzneimittel-Interaktionen</i> (in German) (2010/2011 ed.). Arbeitsgemeinschaft für Pharmazeutische Information. ISBN<span>&nbsp;</span><bdi>978-3-85200-207-1</bdi>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFMaurerGaehwilerBuescherHill1982" class="citation journal cs1">Maurer R, Gaehwiler BH, Buescher HH, Hill RC, Roemer D (August 1982). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346769  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346769'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346769" class="external text external">"Opiate antagonistic properties of an octapeptide somatostatin analog"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>79</b> (15): 4815–7. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1982PNAS...79.4815M  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1982PNAS...79.4815M'" tppabs="https://ui.adsabs.harvard.edu/abs/1982PNAS...79.4815M" class="external text external">1982PNAS...79.4815M</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.79.15.4815  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.79.15.4815'" tppabs="https://doi.org/10.1073%2Fpnas.79.15.4815" class="external text external">10.1073/pnas.79.15.4815</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346769  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346769'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346769" class="external text external">346769</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6126877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6126877'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6126877" class="external text external">6126877</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFAllenBlakeBryceHaggan2000" class="citation journal cs1">Allen MP, Blake JF, Bryce DK, Haggan ME, Liras S, McLean S, Segelstein BE (March 2000). "Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel mu opioid receptor ligands". <i>Bioorganic &amp; Medicinal Chemistry Letters</i>. <b>10</b> (6): 523–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0960-894x%2800%2900034-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0960-894x%2800%2900034-2'" tppabs="https://doi.org/10.1016%2Fs0960-894x%2800%2900034-2" class="external text external">10.1016/s0960-894x(00)00034-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10741545  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10741545'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10741545" class="external text external">10741545</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFMatharuLevyMeeranGoadsby2004" class="citation journal cs1">Matharu MS, Levy MJ, Meeran K, Goadsby PJ (October 2004). "Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study". <i>Annals of Neurology</i>. <b>56</b> (4): 488–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fana.20210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fana.20210'" tppabs="https://doi.org/10.1002%2Fana.20210" class="external text external">10.1002/ana.20210</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15455406  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15455406'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15455406" class="external text external">15455406</a>.</cite></span></li><li id="cite_note-pmid10207228-19"> <span id="mw-reference-text-cite_note-pmid10207228-19" class="mw-reference-text"><cite id="CITEREFUhlAnghelacopoulosFriessBüchler1999" class="citation journal cs1">Uhl W, Anghelacopoulos SE, Friess H, Büchler MW (1999). "The role of octreotide and somatostatin in acute and chronic pancreatitis". <i>Digestion</i>. 60 Suppl 2 (2): 23–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000051477  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000051477'" tppabs="https://doi.org/10.1159%2F000051477" class="external text external">10.1159/000051477</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10207228  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10207228'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10207228" class="external text external">10207228</a>.</cite></span></li><li id="cite_note-pmid18490369-20"> <span id="mw-reference-text-cite_note-pmid18490369-20" class="mw-reference-text"><cite id="CITEREFShimaOhtsuShiraoSasaki2008" class="citation journal cs1">Shima Y, Ohtsu A, Shirao K, Sasaki Y (May 2008). <a href="javascript:if(confirm('https://doi.org/10.1093/jjco/hyn035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jjco/hyn035'" tppabs="https://doi.org/10.1093/jjco/hyn035" class="external text external">"Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction"</a>. <i>Japanese Journal of Clinical Oncology</i>. <b>38</b> (5): 354–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjjco%2Fhyn035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjjco%2Fhyn035'" tppabs="https://doi.org/10.1093%2Fjjco%2Fhyn035" class="external text external">10.1093/jjco/hyn035</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18490369  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18490369'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18490369" class="external text external">18490369</a>.</cite></span></li><li id="cite_note-pmid19238094-21"> <span id="mw-reference-text-cite_note-pmid19238094-21" class="mw-reference-text"><cite id="CITEREFSkagenEinsteinLuceySaid2009" class="citation journal cs1">Skagen C, Einstein M, Lucey MR, Said A (August 2009). "Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome". <i>Journal of Clinical Gastroenterology</i>. <b>43</b> (7): 680–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FMCG.0b013e318188947c  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FMCG.0b013e318188947c'" tppabs="https://doi.org/10.1097%2FMCG.0b013e318188947c" class="external text external">10.1097/MCG.0b013e318188947c</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19238094  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19238094'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19238094" class="external text external">19238094</a>.</cite></span></li><li id="cite_note-patient.info-22"> <span id="mw-reference-text-cite_note-patient.info-22" class="mw-reference-text"><cite id="CITEREFPatient.info2013" class="citation journal cs1">Patient.info (February 2013). <a href="javascript:if(confirm('http://www.patient.info/doctor/Hypotension.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.patient.info/doctor/Hypotension.htm'" tppabs="http://www.patient.info/doctor/Hypotension.htm" class="external text external">"Hypotension"</a>.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-pmid16392238-23"> <span id="mw-reference-text-cite_note-pmid16392238-23" class="mw-reference-text"><cite id="CITEREFKilicSahinGulcanBolat2005" class="citation journal cs1">Kilic D, Sahin E, Gulcan O, Bolat B, Turkoz R, Hatipoglu A (2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336729  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336729'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336729" class="external text external">"Octreotide for treating chylothorax after cardiac surgery"</a>. <i>Texas Heart Institute Journal</i>. <b>32</b> (3): 437–9. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336729  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336729'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336729" class="external text external">1336729</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16392238  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16392238'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16392238" class="external text external">16392238</a>.</cite></span></li><li id="cite_note-pmid16487393-24"> <span id="mw-reference-text-cite_note-pmid16487393-24" class="mw-reference-text"><cite id="CITEREFSiuLam2006" class="citation journal cs1">Siu SL, Lam DS (2006). "Spontaneous neonatal chylothorax treated with octreotide". <i>Journal of Paediatrics and Child Health</i>. <b>42</b> (1–2): 65–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1440-1754.2006.00788.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1440-1754.2006.00788.x'" tppabs="https://doi.org/10.1111%2Fj.1440-1754.2006.00788.x" class="external text external">10.1111/j.1440-1754.2006.00788.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16487393  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16487393'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16487393" class="external text external">16487393</a>.</cite></span></li><li id="cite_note-pmid16242470-25"> <span id="mw-reference-text-cite_note-pmid16242470-25" class="mw-reference-text"><cite id="CITEREFChanRussellWilliamsVan_Arsdell2005" class="citation journal cs1">Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW (November 2005). "Postoperative chylothorax after cardiothoracic surgery in children". <i>The Annals of Thoracic Surgery</i>. <b>80</b> (5): 1864–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.athoracsur.2005.04.048  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.athoracsur.2005.04.048'" tppabs="https://doi.org/10.1016%2Fj.athoracsur.2005.04.048" class="external text external">10.1016/j.athoracsur.2005.04.048</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16242470  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16242470'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16242470" class="external text external">16242470</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><a href="javascript:if(confirm('http://www.ihrfoundation.org/intracranial/hypertension/info/C172/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ihrfoundation.org/intracranial/hypertension/info/C172/'" tppabs="http://www.ihrfoundation.org/intracranial/hypertension/info/C172/" class="external text external">Greek Researchers Investigate Octreotide</a> <a href="javascript:if(confirm('https://web.archive.org/web/20101219053757/http://ihrfoundation.org/intracranial/hypertension/info/C172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20101219053757/http://ihrfoundation.org/intracranial/hypertension/info/C172'" tppabs="https://web.archive.org/web/20101219053757/http://ihrfoundation.org/intracranial/hypertension/info/C172" class="external text external">Archived</a><span> 2010-12-19 at the </span>Wayback Machine Hypertension Research Foundation, accessed 2011-01-02</span></li><li id="cite_note-pmid17700925-27"> <span id="mw-reference-text-cite_note-pmid17700925-27" class="mw-reference-text"><cite id="CITEREFPanagopoulosDeftereosTagarisGryllia2007" class="citation journal cs1">Panagopoulos GN, Deftereos SN, Tagaris GA, Gryllia M, Kounadi T, Karamani O,  et al. (July 2007). "Octreotide: a therapeutic option for idiopathic intracranial hypertension". <i>Neurology, Neurophysiology, and Neuroscience</i>: 1. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17700925  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17700925'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17700925" class="external text external">17700925</a>.</cite></span></li><li id="cite_note-Lustig2003-28"> <span id="mw-reference-text-cite_note-Lustig2003-28" class="mw-reference-text"><cite id="CITEREFLustigHindsRingwald-SmithChristensen2003" class="citation journal cs1">Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE,  et al. (June 2003). <a href="javascript:if(confirm('https://doi.org/10.1210/jc.2002-030003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210/jc.2002-030003'" tppabs="https://doi.org/10.1210/jc.2002-030003" class="external text external">"Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial"</a>. <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>88</b> (6): 2586–92. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fjc.2002-030003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjc.2002-030003'" tppabs="https://doi.org/10.1210%2Fjc.2002-030003" class="external text external">10.1210/jc.2002-030003</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12788859  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12788859'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12788859" class="external text external">12788859</a>.</cite></span></li><li id="cite_note-flier-29"> <span id="mw-reference-text-cite_note-flier-29" class="mw-reference-text"><cite id="CITEREFFlier2004" class="citation journal cs1">Flier JS (January 2004). "Obesity wars: molecular progress confronts an expanding epidemic". <i>Cell</i>. <b>116</b> (2): 337–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0092-8674%2803%2901081-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0092-8674%2803%2901081-X'" tppabs="https://doi.org/10.1016%2FS0092-8674%2803%2901081-X" class="external text external">10.1016/S0092-8674(03)01081-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14744442  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14744442'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14744442" class="external text external">14744442</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFBoulpaep,_Emile_L.Boron,_Walter_F.2003" class="citation book cs1">Boulpaep, Emile L.; Boron, Walter F. (2003). <i>Medical physiologya: A cellular and molecular approach</i>. Philadelphia: Saunders. p.<span>&nbsp;</span>1227. ISBN<span>&nbsp;</span><bdi>978-0-7216-3256-8</bdi>.</cite></span></li><li id="cite_note-Lustig2011-31"> <span id="mw-reference-text-cite_note-Lustig2011-31" class="mw-reference-text"><cite id="CITEREFLustig2011" class="citation journal cs1">Lustig RH (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356006'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356006" class="external text external">"Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment"</a>. <i>Frontiers in Endocrinology</i>. <b>2</b>: 60. doi:<a href="javascript:if(confirm('https://doi.org/10.3389%2Ffendo.2011.00060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3389%2Ffendo.2011.00060'" tppabs="https://doi.org/10.3389%2Ffendo.2011.00060" class="external text external">10.3389/fendo.2011.00060</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356006'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356006" class="external text external">3356006</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22654817  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22654817'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22654817" class="external text external">22654817</a>.</cite></span></li><li id="cite_note-Lustig2006-32"> <span id="mw-reference-text-cite_note-Lustig2006-32" class="mw-reference-text"><cite id="CITEREFLustigGreenwayVelasquez-MieyerHeimburger2006" class="citation journal cs1">Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D,  et al. (February 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540404'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540404" class="external text external">"A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion"</a>. <i>International Journal of Obesity</i>. <b>30</b> (2): 331–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.ijo.0803074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.ijo.0803074'" tppabs="https://doi.org/10.1038%2Fsj.ijo.0803074" class="external text external">10.1038/sj.ijo.0803074</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540404'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540404" class="external text external">1540404</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16158082  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16158082'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16158082" class="external text external">16158082</a>.</cite></span></li><li id="cite_note-Bynfezia_Pen_letter-33"> <span id="mw-reference-text-cite_note-Bynfezia_Pen_letter-33" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213224Orig1s000ltr.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213224Orig1s000ltr.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213224Orig1s000ltr.pdf" class="external text external">"Bynfezia Pen letter"</a> <span class="cs1-format">(PDF)</span>. U.S. Food and Drug Administration (FDA). 28 January 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">16 February</span> 2020</span>.</cite> <figure-inline><span><img src="../I/m/PD-icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/PD-icon.svg.png" data-file-width="196" data-file-height="196" data-file-type="drawing" height="15" width="15"></span></figure-inline><span> </span><i>This article incorporates text from this source, which is in the public domain.</i></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/octreotide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/octreotide'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/octreotide" class="external text external">"Octreotide"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="GH/IGF-1_axis_signaling_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="GH/IGF-1_axis_signaling_modulators" style="font-size:114%;margin:0 4em"><abbr>GH</abbr>/<abbr>IGF-1</abbr> axis signaling modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GH</abbr><br><small>(somatotropin)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Albusomatropin</span></li>
<li>Bovine somatotropin</li>
<li><span class="new">Efpegsomatropin</span></li>
<li><span class="new">Eftansomatropin alfa</span></li>
<li><a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">Growth hormone</a></li>
<li>Human placental lactogen</li>
<li>Placental growth hormone (growth hormone variant)</li>
<li><span class="new">Somagrebove</span></li>
<li><span class="new">Somapacitan</span></li>
<li><span class="new">Somatosalm</span></li>
<li><a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Somatotropin" title="Somatotropin" class="mw-redirect">Somatotropin</a></li>
<li><span class="new">Somatropin pegol</span></li>
<li>Somatrem</li>
<li><span class="new">Sometribove</span></li>
<li><span class="new">Somatrogon (MOD-4023; hGH-CTP)</span></li>
<li><span class="new">Somavaratan</span></li>
<li><span class="new">Somavubove</span></li>
<li><span class="new">Somidobove</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">G120K-hGH</span></li>
<li><a href="Pegvisomant.htm" tppabs="https://ptable.com/wiki/compounds/A/Pegvisomant" title="Pegvisomant">Pegvisomant</a></li></ul>

<ul><li><i>Antisense oligonucleotides:</i> <span class="new">Atesidorsen</span></li></ul>

<ul><li><i>Binding proteins:</i> <abbr>GHBP</abbr></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GHIH</abbr><br><small>(somatostatin)</small></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">BIM-23052</span></li>
<li><span class="new">CH-275</span></li>
<li><span class="new">Cortistatin-14</span></li>
<li><span class="new">Depreotide</span></li>
<li>Edotreotide</li>
<li><span class="new">Ilatreotide</span></li>
<li><span class="new">L-803,087</span></li>
<li><span class="new">L-817,818</span></li>
<li>Lanreotide</li>
<li><span class="new">NNC 26-9100</span></li>
<li>Octreotate</li>
<li><a href="Octreotide.htm" tppabs="https://ptable.com/wiki/compounds/A/Octreotide" title="Octreotide">Octreotide</a></li>
<li>Pasireotide</li>
<li><span class="new">Pentetreotide</span></li>
<li><span class="new">RC-160</span></li>
<li><span class="new">Seglitide</span></li>
<li>Somatostatin (GHIH)</li>
<li><span class="new">Somatostatin (1-28)</span></li>
<li><span class="new">SRIF-14</span></li>
<li><span class="new">SRIF-28</span></li>
<li><span class="new">TT-232</span></li>
<li><a href="Vapreotide.htm" tppabs="https://ptable.com/wiki/compounds/A/Vapreotide" title="Vapreotide">Vapreotide</a></li>
<li><span class="new">Veldoreotide</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">BIM-23056</span></li>
<li><span class="new">Cyclosomatostatin</span></li>
<li><span class="new">CYN-154806</span></li>
<li><span class="new">Satoreotide</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GHRH</abbr><br><small>(somatocrinin)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptide:</i> <span class="new">ALRN-5281</span></li>
<li>CJC-1295</li>
<li><span class="new">Dumorelin</span></li>
<li>GHRH</li>
<li>Modified GRF (1-29)</li>
<li><span class="new">Rismorelin</span></li>
<li><a href="Sermorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sermorelin" title="Sermorelin">Sermorelin</a></li>
<li>Somatorelin</li>
<li>Tesamorelin</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">MZ-5-156</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GHS</abbr><br><small>(ghrelin)</small></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptide:</i> <span class="new">Alexamorelin</span></li>
<li><span class="new">Cortistatin-14</span></li>
<li><span class="new">EP-51216</span></li>
<li>Examorelin (hexarelin)</li>
<li>Ghrelin</li>
<li><span class="new">GHRP-1</span></li>
<li><span class="new">GHRP-3</span></li>
<li><span class="new">GHRP-4</span></li>
<li><span class="new">GHRP-5</span></li>
<li>GHRP-6</li>
<li>Ipamorelin</li>
<li>Lenomorelin</li>
<li><span class="new">Livoletide</span></li>
<li><span class="new">LY-444711</span></li>
<li>Pralmorelin (GHRP-2)</li>
<li>Relamorelin</li>
<li>Tabimorelin</li>
<li>Ulimorelin; <i>Non-peptide:</i> <a href="Adenosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenosine" title="Adenosine">Adenosine</a></li>
<li>Anamorelin</li>
<li>Capromorelin</li>
<li><span class="new">CP-464709</span></li>
<li>Ibutamoren (MK-677)</li>
<li><span class="new">L-692,585</span></li>
<li>Macimorelin</li>
<li>SM-130686; <i>Unsorted:</i> <span class="new">LY-426410</span></li>
<li><span class="new">LY-444711</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">A-778193</span></li>
<li><span class="new">Cortistatin-8</span></li>
<li><span class="new">(<small>D</small>-Lys³)-GHRP-6</span></li>
<li><span class="new">JMV2959</span></li>
<li><span class="new">YIL-781</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>IGF-1</abbr><br><small>(somatomedin)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><i><b>See also:</b> Receptor/signaling modulators • Signaling peptide/protein receptor modulators</i></li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Opioid_receptor_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Opioid_receptor_modulators" style="font-size:114%;margin:0 4em">Opioid receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>MOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists (abridged; see here for a full list):</i> 3-HO-PCP</li>
<li><span class="new">7-Acetoxymitragynine</span></li>
<li>7-Hydroxymitragynine</li>
<li><span class="new">ψ-Akuammigine</span></li>
<li>α-Chlornaltrexamine</li>
<li><span class="new">α-Narcotine</span></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine'" tppabs="https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine" title="Acetyldihydrocodeine">Acetyldihydrocodeine</a></li>
<li>Acetylfentanyl</li>
<li>Acrylfentanyl</li>
<li>Adrenorphin (metorphamide)</li>
<li>AH-7921</li>
<li>Akuammicine</li>
<li><span class="new">Akuammidine</span></li>
<li><a href="Alfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfentanil" title="Alfentanil">Alfentanil</a></li>
<li><a href="Anileridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anileridine" title="Anileridine">Anileridine</a></li>
<li>Apparicine</li>
<li>β-Endorphin</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Benzhydrocodone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Benzylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Benzylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Benzylmorphine" title="Benzylmorphine">Benzylmorphine</a></li>
<li><a href="Bezitramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezitramide" title="Bezitramide">Bezitramide</a></li>
<li>Biphalin</li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>Butyrfentanyl</li>
<li>BW373U86</li>
<li><a href="Carfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Carfentanil" title="Carfentanil">Carfentanil</a></li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li>Chloroxymorphamine</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li>DADLE</li>
<li>DAMGO (DAGO)</li>
<li>Dermorphin</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a></li>
<li><a href="Dextromoramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromoramide" title="Dextromoramide">Dextromoramide</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene (propoxyphene)</a></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Dimenoxadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenoxadol" title="Dimenoxadol">Dimenoxadol</a></li>
<li>Dimethylaminopivalophenone</li>
<li>Eluxadoline</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydrocodeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrocodeine" title="Dihydrocodeine">Dihydrocodeine</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diphenoxylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenoxylate" title="Diphenoxylate">Diphenoxylate</a></li>
<li><a href="Dipipanone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipipanone" title="Dipipanone">Dipipanone</a></li>
<li>Dynorphin A</li>
<li><a href="Embutramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Embutramide" title="Embutramide">Embutramide</a></li>
<li>Endomorphin-1</li>
<li>Endomorphin-2</li>
<li>Eseroline</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Ethylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Ethylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Ethylmorphine" title="Ethylmorphine">Ethylmorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Fluorophen</li>
<li>Frakefamide</li>
<li>Furanylfentanyl</li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li>Hodgkinsine</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphinol" title="Hydromorphinol">Hydromorphinol</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>IBNtxA</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketobemidone</li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Lefetamine</li>
<li>Leu-enkephalin</li>
<li><a href="Levacetylmethadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levacetylmethadol" title="Levacetylmethadol">Levacetylmethadol</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li><a href="Loperamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Loperamide" title="Loperamide">Loperamide</a></li>
<li><span class="new">Loxicodegol</span></li>
<li>Matrine</li>
<li>Meptazinol</li>
<li>Met-enkephalin (metenkefalin)</li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Metkefamide</li>
<li>Metopon</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li>Morphiceptin</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalmexone</li>
<li>Naltalimide</li>
<li><span class="new">Neopine</span></li>
<li>NFEPP</li>
<li>Nicocodeine</li>
<li>Nicodicodine</li>
<li>Nicomorphine</li>
<li><span class="new">NKTR-181</span></li>
<li>Norketamine</li>
<li><a href="Octreotide.htm" tppabs="https://ptable.com/wiki/compounds/A/Octreotide" title="Octreotide">Octreotide</a></li>
<li>Oliceridine</li>
<li>OM-3-MNZ</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li>Oxymorphazone</li>
<li><span class="new">Oxymorphonazine</span></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><span class="new">Oxymorphone phenylhydrazone</span></li>
<li><span class="new">OxyPNPH</span></li>
<li><i>Papaver somniferum</i> (opium)</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>Pericine</li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Piminodine</li>
<li>Piritramide</li>
<li><span class="new">PL-017</span></li>
<li><a href="Prodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prodine" title="Prodine">Prodine</a></li>
<li>Propiram</li>
<li>PZM21</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li><a href="Remifentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Remifentanil" title="Remifentanil">Remifentanil</a></li>
<li><span class="new">Salsolinol</span></li>
<li>SC-17599</li>
<li><a href="Sinomenine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sinomenine" title="Sinomenine">Sinomenine</a></li>
<li><a href="Sufentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Sufentanil" title="Sufentanil">Sufentanil</a></li>
<li>Tapentadol</li>
<li>Tetrahydropapaveroline</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thienorphine</li>
<li>Tianeptine</li>
<li>Tilidine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li>Trimebutine</li>
<li>TRIMU 5</li>
<li><span class="new">TRV734</span></li>
<li><span class="new">Tubotaiwine</span></li>
<li>U-47700</li>
<li>Valorphin</li>
<li>Viminol</li>
<li>Xorphanol</li></ul>

<ul><li><i>PAMs:</i> <span class="new">BMS-986121</span></li>
<li><span class="new">BMS-986122</span></li></ul>

<ul><li><i>Antagonists:</i> (3S,4S)-Picenadol</li>
<li>2-(S)-N,N-(R)-Viminol</li>
<li><span class="new">3CS-nalmefene</span></li>
<li>4-Caffeoyl-1,5-quinide</li>
<li><span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>18-MC</li>
<li><span class="new">α-Gliadin</span></li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Akuammine</li>
<li><a href="Alvimopan.htm" tppabs="https://ptable.com/wiki/compounds/A/Alvimopan" title="Alvimopan">Alvimopan</a></li>
<li>AM-251</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>CTAP</li>
<li><span class="new">CTOP</span></li>
<li><span class="new">Cyclofoxy</span></li>
<li>Cyprodime</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Eptazocine</li>
<li>Gemazocine</li>
<li><span class="new">Ginsenoside R</span></li>
<li>Hyperoside</li>
<li>Ibogaine</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Lobeline</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">Methocinnamox</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylsamidorphan chloride</span></li>
<li>Naldemedine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Nalorphine dinicotinate</li>
<li>Naloxazone</li>
<li>Naloxegol</li>
<li>Naloxol</li>
<li>Naloxonazine</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><span class="new">Naltrexazone</span></li>
<li><span class="new">Naltrexonazine</span></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Oxilorphan</li>
<li>Pawhuskin A</li>
<li><a href="Rimonabant.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimonabant" title="Rimonabant">Rimonabant</a></li>
<li>Quadazocine</li>
<li>Samidorphan</li>
<li>Taxifolin</li></ul>

<ul><li><i>Unknown/unsorted:</i> <a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>DOR</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>7-SIOM</li>
<li><span class="new">ADL-5747 (PF-04856881)</span></li>
<li><span class="new">ADL-5859</span></li>
<li>Alazocine (SKF-10047)</li>
<li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><span class="new">AR-M100390 (ARM390)</span></li>
<li><span class="new">AZD2327</span></li>
<li>β-Endorphin</li>
<li><span class="new">BAM-18P</span></li>
<li>Biphalin</li>
<li>BU-48</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>DADLE</li>
<li>Deltorphin A</li>
<li>Deltorphin I</li>
<li><span class="new">Deltorphin II</span></li>
<li>Desmethylclozapine</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>DPDPE</li>
<li>DPI-221</li>
<li>DPI-3290</li>
<li><span class="new">DSLET</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><span class="new">FIT</span></li>
<li>Fluorophen</li>
<li>Hemorphin-4</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>Ibogaine</li>
<li>Isomethadone</li>
<li><span class="new">JNJ-20788560</span></li>
<li><span class="new">KNT-127</span></li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leu-enkephalin</li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>Met-enkephalin (metenkefalin)</li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>N-Phenethyl-14-ethoxymetopon</li>
<li>Norbuprenorphine</li>
<li><span class="new">NalBzOH</span></li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Proglumide</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RWJ-394674</li>
<li>Samidorphan</li>
<li><span class="new">SB-235863</span></li>
<li>SNC-80</li>
<li><span class="new">SNC-162</span></li>
<li>TAN-67 (SB-205,607)</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thiobromadol (C-8813)</li>
<li>Tonazocine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li><span class="new">TRV250</span></li>
<li>Xorphanol</li>
<li>Zenazocine</li></ul>

<ul><li><i>Antagonists:</i> 4',7-Dihydroxyflavone</li>
<li><span class="new">5'-NTII</span></li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li><span class="new">α-Santolol</span></li>
<li>β-Chlornaltrexamine</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><span class="new">BNTX</span></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>Eluxadoline</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li><span class="new">ICI-154129</span></li>
<li><span class="new">ICI-174864</span></li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylnaltrindole</span></li>
<li><span class="new">N-Benzylnaltrindole</span></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltriben</li>
<li>Naltrindole</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>Quadazocine</li>
<li><span class="new">SDM25N</span></li>
<li>SoRI-9409</li>
<li>Taxifolin</li>
<li>Thienorphine</li></ul>

<ul><li><i>Unknown/unsorted:</i> 18-MC</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>KOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>8-CAC</li>
<li>18-MC</li>
<li>14-Methoxymetopon</li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Adrenorphin (metorphamide)</li>
<li><span class="new">Akuuamicine</span></li>
<li>Alazocine (SKF-10047)</li>
<li><span class="new">Allomatrine</span></li>
<li><span class="new">Apadoline</span></li>
<li>Asimadoline</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Big dynorphin</li>
<li>Bremazocine</li>
<li>BRL-52537</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Cebranopadol</li>
<li>Ciprefadol</li>
<li>CR665</li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>Cyclorphan</li>
<li><a href="Cyprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyprenorphine" title="Cyprenorphine">Cyprenorphine</a></li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li>Diacetylnalorphine</li>
<li>Difelikefalin</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>Dynorphin A</li>
<li>Dynorphin B (rimorphin)</li>
<li>Eluxadoline</li>
<li>Enadoline</li>
<li>Eptazocine</li>
<li><span class="new">Erinacine E</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li>Fedotozine</li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Gemazocine</li>
<li>GR-89696</li>
<li><span class="new">GR-103545</span></li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li><span class="new">HS665</span></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>HZ-2</li>
<li>Ibogaine</li>
<li>ICI-199,441</li>
<li>ICI-204,448</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketazocine</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leumorphin (dynorphin B-29)</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>LPK-26</li>
<li>Lufuradom</li>
<li>Matrine</li>
<li><span class="new">MB-1C-OH</span></li>
<li><a href="Menthol.htm" tppabs="https://ptable.com/wiki/compounds/A/Menthol" title="Menthol">Menthol</a></li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>Moxazocine</li>
<li><span class="new">MR-2034</span></li>
<li><span class="new">N-MPPP</span></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalfurafine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Naltriben</li>
<li>Niravoline</li>
<li>Norbuprenorphine</li>
<li>Norbuprenorphine-3-glucuronide</li>
<li>Noribogaine</li>
<li>Norketamine</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li>Oxilorphan</li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li>Proxorphan</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RB-64</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a> (<a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">salvia</a>)</li>
<li>Salvinorin B ethoxymethyl ether</li>
<li>Salvinorin B methoxymethyl ether</li>
<li>Samidorphan</li>
<li>Spiradoline (U-62,066)</li>
<li><span class="new">TH-030418</span></li>
<li>Thienorphine</li>
<li>Tifluadom</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, desipramine, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li>
<li>U-50488</li>
<li><span class="new">U-54,494A</span></li>
<li>U-69,593</li>
<li>Xorphanol</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>5'-GNTI</li>
<li>6'-GNTI</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>β-Chlornaltrexamine</li>
<li>Buprenorphine/samidorphan</li>
<li><a href="Amentoflavone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amentoflavone" title="Amentoflavone">Amentoflavone</a></li>
<li><span class="new">ANTI</span></li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li><span class="new">Arodyne</span></li>
<li>AT-076</li>
<li>Aticaprant</li>
<li>Axelopran</li>
<li><span class="new">AZ-MTAB</span></li>
<li>Binaltorphimine</li>
<li>BU09059</li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>CERC-501 (LY-2456302)</li>
<li>Clocinnamox</li>
<li><span class="new">Cyclofoxy</span></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><span class="new">DIPPA</span></li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>ECG</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Hyperoside</li>
<li>JDTic</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">LY-2444296</span></li>
<li>LY-2459989</li>
<li><span class="new">LY-2795050</span></li>
<li><span class="new">MeJDTic</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">ML190</span></li>
<li><span class="new">ML350</span></li>
<li><span class="new">MR-2266</span></li>
<li><span class="new">N-Fluoropropyl-JDTic</span></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Norbinaltorphimine</li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>PF-4455242</li>
<li>RB-64</li>
<li>Quadazocine</li>
<li>Taxifolin</li>
<li><span class="new">UPHIT</span></li>
<li>Zyklophin</li></ul>

<ul><li><i>Unknown/unsorted:</i> Akuammicine</li>
<li>Akuammine</li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Ibogamine</li>
<li>Tabernanthine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>NOP</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">(Arg14,Lys15)Nociceptin</span></li>
<li><span class="new">((pF)Phe<sup>4</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">(Phe<sup>1</sup>Ψ(CH<sub>2</sub>-NH)Gly<sup>2</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRWK-NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRIK-NH<sub>2</sub></span></li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li>Cebranopadol</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><span class="new">JNJ-19385899</span></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>MCOPPB</li>
<li><span class="new">MT-7716</span></li>
<li>NNC 63-0532</li>
<li>Nociceptin (orphanin FQ)</li>
<li><span class="new">Nociceptin (1-11)</span></li>
<li><span class="new">Nociceptin (1-13)NH<sub>2</sub></span></li>
<li>Norbuprenorphine</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>Ro64-6198</li>
<li><span class="new">Ro65-6570</span></li>
<li><span class="new">SCH-221510</span></li>
<li><span class="new">SCH-486757</span></li>
<li><span class="new">SR-8993</span></li>
<li><span class="new">SR-16435</span></li>
<li><span class="new">TH-030418</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">(Nphe<sup>1</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li>AT-076</li>
<li><span class="new">BAN-ORL-24</span></li>
<li>BTRX-246040 (LY-2940094)</li>
<li>J-113,397</li>
<li>JTC-801</li>
<li><span class="new">NalBzOH</span></li>
<li><span class="new">Nociceptin (1-7)</span></li>
<li><span class="new">Nocistatin</span></li>
<li>SB-612,111</li>
<li><span class="new">SR-16430</span></li>
<li>Thienorphine</li>
<li><span class="new">Trap-101</span></li>
<li><span class="new">UFP-101</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>β-Casomorphins</li>
<li>Amidorphin</li>
<li><span class="new">BAM-20P</span></li>
<li>Cytochrophin-4</li>
<li><span class="new">Deprolorphin</span></li>
<li>Gliadorphin (gluteomorphin)</li>
<li>Gluten exorphins</li>
<li>Hemorphins</li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a> constituents</li>
<li><span class="new">MEAGL</span></li>
<li><span class="new">MEAP</span></li>
<li><a href="N-Ethylmaleimide.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Ethylmaleimide" title="N-Ethylmaleimide">NEM</a></li>
<li>Neoendorphins</li>
<li>Nepetalactone (catnip)</li>
<li><span class="new">Peptide B</span></li>
<li><span class="new">Peptide E</span></li>
<li><span class="new">Peptide F</span></li>
<li><span class="new">Peptide I</span></li>
<li>Rubiscolins</li>
<li><span class="new">Soymorphins</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Enkephalinase inhibitors:</i> Amastatin</li>
<li><span class="new">BL-2401</span></li>
<li><a href="Candoxatril.htm" tppabs="https://ptable.com/wiki/compounds/A/Candoxatril" title="Candoxatril">Candoxatril</a></li>
<li><a href="Phenylalanine.htm#D-,_L-_and_DL-phenylalanine" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine#D-,_L-_and_DL-phenylalanine" title="Phenylalanine"><span style="font-size:90%;">D </span>-Phenylalanine</a></li>
<li><span class="new">Dexecadotril (retorphan)</span></li>
<li>Ecadotril (sinorphan)</li>
<li>Kelatorphan</li>
<li><a href="Racecadotril.htm" tppabs="https://ptable.com/wiki/compounds/A/Racecadotril" title="Racecadotril">Racecadotril (acetorphan)</a></li>
<li>RB-101</li>
<li>RB-120</li>
<li>RB-3007</li>
<li><span class="new">Opiorphan</span></li>
<li>Selank</li>
<li>Semax</li>
<li>Spinorphin</li>
<li><a href="Thiorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiorphan" title="Thiorphan">Thiorphan</a></li>
<li>Tynorphin</li>
<li><a href="Ubenimex.htm" tppabs="https://ptable.com/wiki/compounds/A/Ubenimex" title="Ubenimex">Ubenimex (bestatin)</a></li></ul>

<ul><li><i>Propeptides:</i> β-Lipotropin (proendorphin)</li>
<li>Prodynorphin</li>
<li>Proenkephalin</li>
<li><span class="new">Pronociceptin</span></li>
<li>Proopiomelanocortin (POMC)</li></ul>

<ul><li><i>Others:</i> Kyotorphin (met-enkephalin releaser/degradation stabilizer)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Signaling peptide/protein receptor modulators</i></div></td></tr></tbody></table></div>







<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>